Pierre Legault
Chairman at BICYCLE THERAPEUTICS PLC
Net worth: 2 M $ as of 2024-04-29
Network origin in Pierre Legault first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
Harvard Business School
312
| College/University | Other Consumer Services | 312 |
McGill University
156
| College/University | Other Consumer Services | 156 |
| Public Company | Biotechnology | 30 | |
| Public Company | Biotechnology | 28 | |
| Extinct | Pharmaceuticals: Major | 27 | |
HEC Montréal
25
| College/University | Other Consumer Services | 25 |
Roivant Sciences, Inc.
 Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY.
23
| Subsidiary | Pharmaceuticals: Major | 23 |
Aventis Pharmaceuticals, Inc.
 Aventis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aventis Pharmaceuticals, Inc. develops, manufactures and markets pharmaceutical products. The company was founded in 1950 and is headquartered in Bridgewater, NJ.
23
| Subsidiary | Pharmaceuticals: Major | 23 |
| Public Company | Drugstore Chains | 20 | |
Artios Pharma Ltd.
 Artios Pharma Ltd. Pharmaceuticals: MajorHealth Technology Artios Pharma Ltd. manufactures pharmaceutical products. The firm develops a DNA Damage Response (DDR) is a cancer therapy. The company was founded by Niall Martin in May 2016 and is headquartered in London, the United Kingdom.
19
| Holding Company | Pharmaceuticals: Major | 19 |
| Subsidiary | Pharmaceuticals: Major | 18 | |
| Subsidiary | Pharmaceuticals: Major | 17 | |
Hoechst Marion Roussel, Inc.
15
| Subsidiary | 15 | |
Sanofi-Aventis U.S. LLC
 Sanofi-Aventis U.S. LLC Pharmaceuticals: MajorHealth Technology Sanofi-Aventis U.S. LLC engages in the provision of pharmaceutical products. It discovers, develops, produces and markets innovative therapies. The firm extensive research and development efforts are focused on health care challenges in cardiology, oncology and internal medicine, as well as metabolic diseases, central nervous system disorders, ophthalmology and vaccines. The company is headquartered in Bridgewater, NJ.
13
| Subsidiary | Pharmaceuticals: Major | 13 |
| Subsidiary | Pharmaceuticals: Major | 13 | |
Urovant Sciences, Inc.
 Urovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Sumitomo Chemical Co., Ltd., Urovant Sciences, Inc. is a pharmaceutical company that prioritizes diversity, equity, and inclusion in rewriting how care is provided in urology. The company is based in Irvine, CA and offers programs to improve patient care, with a current focus on overactive bladder. Urovant Sciences is expanding opportunities to help patients in and beyond, with links to marketed product sites for patients and healthcare professionals, plus patent information. Recently, Sumitovant Biopharma Ltd. announced that its parent company Sumitomo Pharma Co., Ltd. will combine its wholly owned subsidiaries to form Sumitomo Pharma America, Inc., which will include Urovant Sciences and other subsidiaries.
13
| Subsidiary | Pharmaceuticals: Major | 13 |
| Public Company | Pharmaceuticals: Major | 11 | |
Sitryx Therapeutics Ltd.
 Sitryx Therapeutics Ltd. Medical SpecialtiesHealth Technology Sitryx Therapeutics Ltd. Focuses on regulating cell metabolism to develop disease-modifying therapeutics in immuno-oncology and immuno-inflammation. It treats cancer and inflammatory conditions by targeting the metabolism of immune cells. The company was founded by Houman Ashrafian, Paul-Peter Tak, Luke O'Neill, Jonathan Powell, Jeff Rathmell and Michael Rosenblum and is headquartered in London, the United Kingdom.
10
| Holding Company | Medical Specialties | 10 |
| Subsidiary | Medical Distributors | 9 | |
Regado Biosciences, Inc.
 Regado Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Regado Biosciences, Inc. is a biopharmaceutical company, which engages in the discovery and development of therapies in cardiovascular medicine using actively controlled aptamer technology. The company is focusing on new products for antithrombotic indications in the acute care and sub-acute care therapeutic setting. Its paired aptamer-active control agent technology is designed to give physicians the ability to directly control the degree of antithrombotic activity in real time on a "per patient, per setting" basis. The company's clinical programs are specifically concentrated on acute and sub-acute care injectable anticoagulants. Regado Biosciences was founded by Eli Gilboa, Bruce A. Sullenger and Christopher P. Rusconi on December 19, 2001 and is headquartered in Basking Ridge, NJ.
9
| Extinct | Pharmaceuticals: Major | 9 |
Bicycle Therapeutics, Inc.
 Bicycle Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of Bicycle Therapeutics Plc, Bicycle Therapeutics, Inc. develops medicines and therapeutics for cancer treatment. The company is based in Lexington, MA. The company was founded in 2009 by Kevin Lee. Kevin Lee has been the CEO since 2009.
7
| Subsidiary | Pharmaceuticals: Major | 7 |
BicycleTx Ltd.
 BicycleTx Ltd. Miscellaneous Commercial ServicesCommercial Services Founded in 2017, part of Bicycle Therapeutics Plc, BicycleTx Ltd. provides business support services. The company is based in Babraham, UK.
6
| Subsidiary | Miscellaneous Commercial Services | 6 |
| Extinct | Pharmaceuticals: Major | 6 | |
Iroko Pharmaceuticals LLC
 Iroko Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Iroko Pharmaceuticals LLC develops and distributes pharmaceutical products. It provides approved US products, marketed global, medical information and product patents. The company was founded in 2007 and is headquartered in Philadelphia, PA.
5
| Subsidiary | Pharmaceuticals: Major | 5 |
Egle Therapeutics SAS
 Egle Therapeutics SAS Miscellaneous Commercial ServicesCommercial Services Egle Therapeutics SAS is a biotech company based in Paris, France. Egle Therapeutics develops first-in-class immunotherapies targeting immune suppressor regulatory T cells (Tregs) for oncology and autoimmune diseases. The French company leverages its translational-based target discovery platform to unveil novel therapeutic Treg targets and computationally designed immunocytokines acting as antagonists or as selective Treg-agonists. The company was founded in 2020 by Luc Boblet, a serial biotech entrepreneur, and Dr. Eliane Piaggio, a renowned immunologist.
5
| Holding Company | Miscellaneous Commercial Services | 5 |
Aventis, Inc.
5
| Subsidiary | 5 | |
| Subsidiary | Medical Distributors | 4 | |
Sanofi-Aventis Groupe SA
 Sanofi-Aventis Groupe SA Financial ConglomeratesFinance Sanofi-Aventis Groupe SA operates as a holding company, with interest in the manufacture and distribution of pharmaceutical products. The company was founded on December 19, 1995 and is headquartered in Paris, France.
2
| Subsidiary | Financial Conglomerates | 2 |
| Public Company | Pharmaceuticals: Major | 2 | |
Marion Merrell Dow, Inc.
1
| Extinct | Pharmaceuticals: Major | 1 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Pierre Legault via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| UROVANT SCIENCES LTD. | Pharmaceuticals: Major | Comptroller/Controller/Auditor Chief Executive Officer Director/Board Member Chief Executive Officer Chief Tech/Sci/R&D Officer Director/Board Member | |
| University of Cambridge | College/University | Undergraduate Degree Undergraduate Degree Doctorate Degree Doctorate Degree Doctorate Degree | |
| AVANIR PHARMACEUTICALS INC | Pharmaceuticals: Major | Director of Finance/CFO Chief Executive Officer Director/Board Member Director/Board Member Sales & Marketing | |
| ALLERGAN PLC | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal General Counsel Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Schering-Plough Corp.
 Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member Corporate Officer/Principal Corporate Officer/Principal Sales & Marketing | |
| SIO GENE THERAPIES INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chief Administrative Officer Director/Board Member Director/Board Member | |
| The Wharton School of the University of Pennsylvania | College/University | Graduate Degree Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Graduate Degree Corporate Officer/Principal Undergraduate Degree Graduate Degree | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Human Resources Officer Corporate Officer/Principal Corporate Officer/Principal Investor Relations Contact | |
| ELEDON PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director of Finance/CFO Chairman Director of Finance/CFO Director/Board Member | |
| Rutgers State University of New Jersey | College/University | Undergraduate Degree Graduate Degree Undergraduate Degree | |
SV Health Investors LLP
 SV Health Investors LLP Investment ManagersFinance SV Health Investors LLP (SV Health Investors) is a venture capital firm founded in 1994 by Peter McPartland. The firm is headquartered in London. | Investment Managers | Private Equity Investor Private Equity Investor Private Equity Investor | |
| POXEL | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
| University of Oxford | College/University | Undergraduate Degree Doctorate Degree Undergraduate Degree | |
Crown Laboratories, Inc.
 Crown Laboratories, Inc. Pharmaceuticals: OtherHealth Technology Crown Laboratories, Inc. provides pharmaceutical and consumer products. Its products include aesthetics, beauty, therapeutic and prescription products. The firm offers contract development, manufacturing, production and packaging servicers. The company was founded by Don Kilday and Jeff Bedard in November 2000 and is headquartered in Johnson City, TN. | Pharmaceuticals: Other | Director/Board Member Director/Board Member Chairman | |
| Yale University | College/University | Undergraduate Degree Graduate Degree Undergraduate Degree | |
| Dartmouth College | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| HealthCare Institute of New Jersey | Director/Board Member Director/Board Member Director/Board Member | ||
Forest Pharmaceuticals, Inc.
 Forest Pharmaceuticals, Inc. Forest ProductsNon-Energy Minerals Forest Pharmaceuticals, Inc. manufactures, distributes, and sells forest-branded prescription products in the United States and Puerto Rico. The company is headquartered in St. Louis, MO. | Forest Products | Chief Executive Officer Sales & Marketing Sales & Marketing | |
| TREVENA, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Comptroller/Controller/Auditor | |
BioNJ, Inc.
 BioNJ, Inc. Miscellaneous Commercial ServicesCommercial Services BioNJ, Inc. is based in Trenton, NJ. BioNJ, Inc. is a life sciences trade association with nearly 400 member companies. The company supports the discovery, development, and commercialization of therapies and cures that save and improve lives. BioNJ drives capital formation, fosters entrepreneurship, advocates for medical innovation, provides access to talent and education, and offers critical commercial resources. The company also serves as a clearinghouse for funding information and opportunities. The company was founded in 1994 by James J. Marino, Jayne C. Gershkowitz, Abraham Abuchowski. The CEO is Debbie Hart. | Miscellaneous Commercial Services | Chairman Director/Board Member Director/Board Member | |
| ALLERGAN, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Sales & Marketing Chief Executive Officer | |
| GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| MOMENTA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director of Finance/CFO Director/Board Member Chief Tech/Sci/R&D Officer | |
| ROIVANT SCIENCES LTD. | Pharmaceuticals: Major | Chairman Chief Executive Officer President | |
| Imperial College London | College/University | Masters Business Admin Doctorate Degree | |
| Universidad Autónoma de Madrid | College/University | Doctorate Degree Doctorate Degree | |
RightCare Solutions, Inc.
 RightCare Solutions, Inc. Packaged SoftwareTechnology Services Right Care Solutions, Inc. develops a discharge decision support platform. It offers risk assessment by flagging patients at risk for readmissions when admitted to the hospital. The solution also provides recommendations regarding post-acute care and community-based services for patients. The company was founded by Eric M. Heil and Kathyrn H. Bowles in 2011 and is headquartered in Horsham, PA. | Packaged Software | Director/Board Member Chief Operating Officer | |
| CAREDX, INC | Medical Specialties | Director/Board Member Director of Finance/CFO | |
Transposon Therapeutics, Inc.
 Transposon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Transposon Therapeutics, Inc. provides pharmaceutical products. The company is headquartered in Westport, CT. | Pharmaceuticals: Major | Director/Board Member Chairman | |
| TENAX THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
| University of Pennsylvania | College/University | Graduate Degree Doctorate Degree | |
| Faculty of Pharmaceutical Medicine | Corporate Officer/Principal Director/Board Member | ||
| University of Amsterdam | College/University | Doctorate Degree Corporate Officer/Principal | |
Nabriva Therapeutics GmbH
 Nabriva Therapeutics GmbH Pharmaceuticals: MajorHealth Technology Nabriva Therapeutics GmbH is a clinical-stage biopharmaceutical company, which engages in the research and development of novel anti-infective agents to treat serious infections. It focuses on the pleuromutilin class of antibiotics. The company was founded by Rodger Novak in October 2005 and is headquartered in Vienna, Austria. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
| University College London | College/University | Undergraduate Degree Doctorate Degree | |
| The Royal College of Physicians | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
Alchemab Therapeutics Ltd.
 Alchemab Therapeutics Ltd. BiotechnologyHealth Technology Alchemab Therapeutics Ltd. engages in developing of antibodies. It focuses on discovering and developing novel therapeutics for patients. The company was founded in 2019 and is headquartered in Kings Cross, the Unite Kingdom. | Biotechnology | Director/Board Member Director/Board Member | |
Otic Pharma Ltd.
 Otic Pharma Ltd. Pharmaceuticals: MajorHealth Technology Otic Pharma Ltd. develops and manufactures pharmaceutical products for ear indications. Its products include FoamOtic Externa, FoamOtic Sinus, Foam-O-Vet, and FoamOtic Media. The company was founded by Gad Riesenfeld, Rodrigo A. Yelin and Eran Eilat in March 2008 and is headquartered in Irvine, CA. | Pharmaceuticals: Major | Director of Finance/CFO Chairman | |
| BAUSCH + LOMB CORPORATION | Medical Specialties | Chief Executive Officer General Counsel | |
Allergan GI Corp.
 Allergan GI Corp. BiotechnologyHealth Technology Allergan GI Corp. develops peptide therapeutics for the treatment of gastrointestinal disorders. It provides RM-493 a small-peptide melanocortin-4 receptor agonist, for the treatment of obesity and diabetes, and RM-131 a small-peptide ghrelin agonist, for the treatment of diabetic gastro paresis and other gastrointestinal functional disorders. The company was founded by Bart Henderson and Elizabeth Stoner in 2008 and is headquartered in Madison, NJ. | Biotechnology | President Treasurer | |
| University of Tennessee | College/University | Masters Business Admin Masters Business Admin |
Statistics
International
| United States | 34 |
| United Kingdom | 10 |
| France | 3 |
| Bermuda | 2 |
| Ireland | 2 |
Sectoral
| Health Technology | 28 |
| Consumer Services | 15 |
| Finance | 3 |
| Commercial Services | 3 |
| Non-Energy Minerals | 2 |
Operational
| Director/Board Member | 640 |
| Corporate Officer/Principal | 227 |
| Independent Dir/Board Member | 156 |
| Chief Executive Officer | 120 |
| President | 117 |
Most connected contacts
| Insiders | |
|---|---|
| Raphaël Wisniewski | 45 |
| Brenton Saunders | 38 |
| George Bickerstaff | 37 |
| Barbara Dalton | 35 |
| Chen-Ming Yu | 33 |
| Ambrose Bailey | 32 |
| Kate Bingham | 31 |
| René Kuijten | 30 |
| Francois Nader | 28 |
| Dennis Podlesak | 27 |
| Briggs Morrison | 26 |
| Carol Brosgart | 25 |
| Jose-Carlos Gutiérrez-Ramos | 24 |
| Timothy Rothwell | 24 |
| James Robinson | 23 |
- Stock Market
- Insiders
- Pierre Legault
- Company connections
